Improvement of Skeletal Muscle Mass after Ledipasvir and Sofosbuvir Treatment for Hepatitis C Virus in Decompensated Liver Cirrhosis

por Sakamori, Ryotaro, Yamada, Ryoko, Shinkai, Kazuma, Doi, Akira, Tahata, Yuki, Shigekawa, Minoru, Kodama, Takahiro, Hikita, Hayato, Yamada, Tomomi, Tatsumi, Tomohide, Takehara, Tetsuo
Publicado 2021

Incidence and risk factors of hepatocellular carcinoma in patients with hepatitis C who achieved a sustained virological response through direct‐acting antiviral agents among the w...

por Hagiwara, Hideki, Ito, Yoshiki, Ohta, Takashi, Nozaki, Yasutoshi, Iwamoto, Takayuki, Hosui, Atsushi, Hiramatsu, Naoki, Tahata, Yuki, Sakamori, Ryotaro, Hikita, Hayato, Hayashi, Norio
Publicado 2022

Hepatocellular Carcinoma in a Patient with Tetralogy of Fallot: A Case Report and Literature Review

por Hyun Sung, Ji, Sakamori, Ryotaro, Yamada, Ryoko, Yoshioka, Teppei, Sakane, Sadatsugu, Tahata, Yuki, Shigekawa, Minoru, Kodama, Takahiro, Hikita, Hayato, Tatsumi, Tomohide, Takehara, Tetsuo
Publicado 2021

The First Case of Coil Embolization for Left Gastric Vein Aneurysm with Liver Cirrhosis: A Case Report and Review of the Literature

por Kato, Seiya, Sakamori, Ryotaro, Yamada, Ryoko, Murai, Kazuhiro, Yoshioka, Teppei, Tahata, Yuki, Shigekawa, Minoru, Kodama, Takahiro, Hikita, Hayato, Hongyo, Hidenari, Ono, Yusuke, Higashihara, Hiroki, Tatsumi, Tomohide, Takehara, Tetsuo
Publicado 2021

White Adipose Tissue Autophagy and Adipose-Liver Crosstalk Exacerbate Nonalcoholic Fatty Liver Disease in Mice

por Sakane, Sadatsugu, Hikita, Hayato, Shirai, Kumiko, Myojin, Yuta, Sasaki, Youichi, Kudo, Shinnosuke, Fukumoto, Kenji, Mizutani, Naoki, Tahata, Yuki, Makino, Yuki, Yamada, Ryoko, Kodama, Takahiro, Sakamori, Ryotaro, Tatsumi, Tomohide, Takehara, Tetsuo
Publicado 2021

Serum amyloid P component and pro-platelet basic protein in extracellular vesicles or serum are novel markers of liver fibrosis in chronic hepatitis C patients

por Shirai, Kumiko, Hikita, Hayato, Sakane, Sadatsugu, Narumi, Ryohei, Adachi, Jun, Doi, Akira, Tanaka, Satoshi, Tahata, Yuki, Yamada, Ryoko, Kodama, Takahiro, Sakamori, Ryotaro, Tatsumi, Tomohide, Mita, Eiji, Tomonaga, Takeshi, Takehara, Tetsuo
Publicado 2022

Pre-existing minor variants with NS5A L31M/V-Y93H double substitution are closely linked to virologic failure with asunaprevir plus daclatasvir treatment for genotype 1b hepatitis...

por Morishita, Naoki, Sakamori, Ryotaro, Yamada, Tomomi, Kai, Yugo, Tahata, Yuki, Urabe, Ayako, Yamada, Ryoko, Kodama, Takahiro, Hikita, Hayato, Doi, Yoshinori, Tamura, Shinji, Hagiwara, Hideki, Imai, Yasuharu, Iio, Sadaharu, Tatsumi, Tomohide, Takehara, Tetsuo
Publicado 2020

Inhibition of nonhomologous end joining‐mediated DNA repair enhances anti‐HBV CRISPR therapy

por Murai, Kazuhiro, Kodama, Takahiro, Hikita, Hayato, Shimoda, Akiyoshi, Fukuoka, Makoto, Fukutomi, Keisuke, Shigeno, Satoshi, Shiode, Yuto, Motooka, Daisuke, Higuchi, Yuichiro, Miyakawa, Kei, Suemizu, Hiroshi, Ryo, Akihide, Tahata, Yuki, Makino, Yuki, Yamada, Ryoko, Sakamori, Ryotaro, Tatsumi, Tomohide, Takehara, Tetsuo
Publicado 2022

Liver Fibrosis Is Associated With Corrected QT Prolongation During Ledipasvir/Sofosbuvir Treatment for Patients With Chronic Hepatitis C

por Tahata, Yuki, Sakamori, Ryotaro, Urabe, Ayako, Morishita, Naoki, Yamada, Ryoko, Yakushijin, Takayuki, Hiramatsu, Naoki, Doi, Yoshinori, Kaneko, Akira, Hagiwara, Hideki, Yamada, Yukinori, Hijioka, Taizo, Inada, Masami, Tamura, Shinji, Imai, Yasuharu, Furuta, Kunimaro, Kodama, Takahiro, Hikita, Hayato, Tatsumi, Tomohide, Takehara, Tetsuo
Publicado 2018

Interleukin-6 Is a Circulating Prognostic Biomarker for Hepatocellular Carcinoma Patients Treated with Combined Immunotherapy

por Myojin, Yuta, Kodama, Takahiro, Sakamori, Ryotaro, Maesaka, Kazuki, Matsumae, Takayuki, Sawai, Yoshiyuki, Imai, Yasuharu, Ohkawa, Kazuyoshi, Miyazaki, Masanori, Tanaka, Satoshi, Mita, Eiji, Tawara, Seiichi, Yakushijin, Takayuki, Nozaki, Yasutoshi, Hagiwara, Hideki, Tahata, Yuki, Yamada, Ryoko, Hikita, Hayato, Tatsumi, Tomohide, Takehara, Tetsuo
Publicado 2022

Transcriptomics Identify Thrombospondin‐2 as a Biomarker for NASH and Advanced Liver Fibrosis

por Kozumi, Kazuhiro, Kodama, Takahiro, Murai, Hiroki, Sakane, Sadatsugu, Govaere, Olivier, Cockell, Simon, Motooka, Daisuke, Kakita, Naruyasu, Yamada, Yukinori, Kondo, Yasuteru, Tahata, Yuki, Yamada, Ryoko, Hikita, Hayato, Sakamori, Ryotaro, Kamada, Yoshihiro, Daly, Ann K., Anstee, Quentin M., Tatsumi, Tomohide, Morii, Eiichi, Takehara, Tetsuo
Publicado 2021

Fucosylated haptoglobin is a novel predictive marker of hepatocellular carcinoma after hepatitis C virus elimination in patients with advanced liver fibrosis

por Shirai, Kumiko, Hikita, Hayato, Sakamori, Ryotaro, Doi, Akira, Tahata, Yuki, Sakane, Sadatsugu, Kamada, Yoshihiro, Murai, Kazuhiro, Nishio, Akira, Yamada, Ryoko, Kodama, Takahiro, Nozaki, Yasutoshi, Kakita, Naruyasu, Ishida, Hisashi, Nakanishi, Fumihiko, Morishita, Naoki, Imanaka, Kazuho, Sakakibara, Mitsuru, Tatsumi, Tomohide, Miyoshi, Eiji, Takehara, Tetsuo
Publicado 2022

Thrombospondin-2 as a Predictive Biomarker for Hepatocellular Carcinoma after Hepatitis C Virus Elimination by Direct-Acting Antiviral

por Matsumae, Takayuki, Kodama, Takahiro, Tahata, Yuki, Myojin, Yuta, Doi, Akira, Nishio, Akira, Yamada, Ryoko, Nozaki, Yasutoshi, Oshita, Masahide, Hiramatsu, Naoki, Morishita, Naoki, Ohkawa, Kazuyoshi, Hijioka, Taizo, Sakakibara, Mitsuru, Doi, Yoshinori, Kakita, Naruyasu, Yakushijin, Takayuki, Sakamori, Ryotaro, Hikita, Hayato, Tatsumi, Tomohide, Takehara, Tetsuo
Publicado 2023

Circulating Cell-Free DNA Profiling Predicts the Therapeutic Outcome in Advanced Hepatocellular Carcinoma Patients Treated with Combination Immunotherapy

por Matsumae, Takayuki, Kodama, Takahiro, Myojin, Yuta, Maesaka, Kazuki, Sakamori, Ryotaro, Takuwa, Ayako, Oku, Keiko, Motooka, Daisuke, Sawai, Yoshiyuki, Oshita, Masahide, Nakabori, Tasuku, Ohkawa, Kazuyoshi, Miyazaki, Masanori, Tanaka, Satoshi, Mita, Eiji, Tawara, Seiichi, Yakushijin, Takayuki, Nozaki, Yasutoshi, Hagiwara, Hideki, Tahata, Yuki, Yamada, Ryoko, Hikita, Hayato, Tatsumi, Tomohide, Takehara, Tetsuo
Publicado 2022

Pretreatment with antibiotics is associated with reduced therapeutic response to atezolizumab plus bevacizumab in patients with hepatocellular carcinoma

por Maesaka, Kazuki, Sakamori, Ryotaro, Yamada, Ryoko, Doi, Akira, Tahata, Yuki, Ohkawa, Kazuyoshi, Oshita, Masahide, Miyazaki, Masanori, Yakushijin, Takayuki, Nozaki, Yasutoshi, Matsumoto, Kengo, Tanaka, Satoshi, Kaneko, Akira, Iio, Sadaharu, Nawa, Takatoshi, Yamada, Yukinori, Morishita, Naoki, Usui, Takeo, Hiramatsu, Naoki, Doi, Yoshinori, Sakakibara, Mitsuru, Imanaka, Kazuho, Yoshida, Yuichi, Kodama, Takahiro, Hikita, Hayato, Tatsumi, Tomohide, Takehara, Tetsuo
Publicado 2023

Posttreatment liver function, but not baseline liver function stratifies patient survival after direct-acting antiviral treatment in decompensated cirrhosis with hepatitis C virus

por Tahata, Yuki, Hikita, Hayato, Mochida, Satoshi, Enomoto, Nobuyuki, Ido, Akio, Kuroda, Hidekatsu, Miki, Daiki, Kurosaki, Masayuki, Hiasa, Yoichi, Sakamori, Ryotaro, Kawada, Norifumi, Yamashita, Taro, Suda, Goki, Yatsuhashi, Hiroshi, Yoshiji, Hitoshi, Kato, Naoya, Takami, Taro, Nakao, Kazuhiko, Matsuura, Kentaro, Asahina, Yasuhiro, Itoh, Yoshito, Tateishi, Ryosuke, Nakamoto, Yasunari, Kakazu, Eiji, Terai, Shuji, Shimizu, Masahito, Ueno, Yoshiyuki, Akuta, Norio, Miyazaki, Masanori, Nozaki, Yasutoshi, Kabayama, Masayuki, Sobue, Satoshi, Moriuchi, Akihiro, Miyaki, Tomokatsu, Kodama, Takahiro, Tatsumi, Tomohide, Yamada, Tomomi, Takehara, Tetsuo
Publicado 2023